Pharmacokinetic model and calculation of absorbed doses in radionuclide therapy of thyroid cancer
https://doi.org/10.22328/2079-5343-2019-10-4-80-86
Abstract
Purpose. To create a model of pharmacokinetics of thyroid-stimulating radiopharmaceuticals (Na131I), to determine the transport constants of thyroid metabolism and excretion by comparing the model results with quantitative radiometric data of patients with thyroid cancer, as well as to calculate the threshold and therapeutic absorbed doses in the thyroid gland on the basis of this model taking into account the effects of ablation.
Materials and methods. The principles and methods of pharmacokinetics (compartment simulation), method of Hooke-Jeeves for finding the minimum of function of several variables when determining the values of the parameters of communications between compartments using quantitative data radiometry of the thyroid tissue of five patients entered radiopharmaceutical, methods of calculation of absorbed doses was found through the process of modeling the cumulative activity of the radiopharmaceutical in the thyroid gland.
Results. A two-compartment model of the kinetics of a thyroid-stimulating radiopharmaceutical was developed taking into account the radiation damage of thyroid tissue residual after thyroidectomy as a result of internal irradiation during radionuclide therapy. Kinetic curves of changes in radiopharmaceutical activity (time-activity curves) in the model compartments for five patients with thyroid cancer were obtained. On the basis of this model calculations of individual threshold and total absorbed doses in thyroid tissue are carried out.
Conclusion. The developed pharmacokinetic model allows to describe the kinetics of radiopharmaceuticals in patients with thyroid cancer. On the Activity-time curves for thyroid tissue there is a characteristic fracture at the time of reaching the threshold dose and then a sharp decline due to the destruction of thyroid tissue as a result of the effects of ablation.
About the Author
A. V. Matveev
Dostoevsky Omsk State University
Russian Federation
Russian Federation
Alexander V. Matveev
OmskReferences
1. Chen C.Y., Chang P.J., Changlai S.P., Pan L.K. Effective Half Life of Iodine for Five Thyroidectomy Patients Using an in vivo Gamma Camera Approach // Journal of Radiation Research. 2007. Vol. 48, No. 6. P. 485-493. doi: 10.1269/jrr.07031.
2. Lipanova N.N., Klepov A.N., Narkevich B.Ya. Treatment Planning and Dose Monitoring for Radioiodine Therapy of Thyroid Cancer // Medical Radiology and Radiation Safety. 2012. Vol. 57. No. 3. P. 53-65 (In Russ.).
3. Vlasova O.P., Klepov A.N., Matusevich E.S., Potchulko E.P. Mathematic Stimulation for Dosimetric Development of Radioiodine Therapy in Patients with Thyroid. Journal of New Medical Technologies, 2008, Vol. 15, No. 1, рр. 17-19. (In Russ.).
4. Vlasova O.P., Klepov A.N., Matusevich E.S., Kurachenko Yu.A. Development of Technology in Individual Dosimetric Planning for Radioiodine Therapy of the Thyroid Disease. Almanac of Clinical Medicine, 2008, No. 17-1, рр. 303-306. (In Russ.).
5. Cyb A.F., Dreval A.V., Garbuzov P.I. Radioiodine Therapy of Thyrotoxicosis: Guide. Moscow, 2009, 160 p. (In Russ.).
6. Silberstein E.B. Comparison of Outcomes After 123I Versus 131I Preablation Imaging Before Radioiodine Ablation in Differentiated Thyroid Carcinoma // The Journal of Nuclear Medicine. 2007. Vol. 48, No. 7. P. 1043-1046. DOI: 10.2967/jnumed.107.040311.
7. Sergienko V.I., Dzhelliff R., Bondareva I.B. Applied Pharmacokinetics: Main Provisions and Clinical Application. Moscow, 2003, 208 p. (In Russ.).
8. Huk R., Dzhivs T.A. Direct Search of Solutions of Numerical and Statistical Problems. Moscow, 1961, 219 p. (In Russ.).
9. Matveev A.V., Noskovec D.Yu. Pharmacokinetic Modeling and Dosimetric Planning of Radioiodine Therapy of Thyrotoxicosis. Herald of Omsk University, 2014, No. 4, рр. 57-64 (In Russ.).
10. Pryma D.A., Mandel S.J. Radioiodine Therapy for Thyroid Cancer in the Era of Risk Stratification and Alternative Targeted Therapies // The Journal of Nuclear Medicine. 2014. Vol. 55, No. 9. P. 1485-1491. DOI: 10.2967/jnu-med.113.131508.
Review
For citations:
Matveev A.V. Pharmacokinetic model and calculation of absorbed doses in radionuclide therapy of thyroid cancer. Diagnostic radiology and radiotherapy. 2019;(4):80-86. (In Russ.) https://doi.org/10.22328/2079-5343-2019-10-4-80-86
Views:
755
Email this article 